Literature DB >> 31012531

Fatal diffuse pulmonary fat microemboli following reperfusion in liver transplantation with the use of marginal steatotic allografts.

David M Rosenfeld1, Maxwell L Smith2, David P Seamans1, Emmanouil Giorgakis3, Brantley D Gaitan1, Narjeet Khurmi1, Bashar A Aqel4, Kunam S Reddy3.   

Abstract

Organ shortage is a major cause of delayed liver transplantation and increased waitlist time. The level of donor steatosis is a significant determinant in organ selection. Scarcity of organs has led some programs to expand their acceptable criteria for the percentage of steatosis. We report two cases of liver transplantation of steatotic donor organs that resulted in mortality within hours from transplantation. Postmortem analysis showed evidence of diffuse pulmonary fat microemboli likely originating from the donor organ, with marked preservation reperfusion injury. The mechanism of diffuse fat microemboli in this setting and possible relationship to other perioperative syndromes (transfusion-related lung injury, acute kidney injury, and postreperfusion syndrome) is discussed.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  anesthesia/pain management; donors and donation: extended criteria; ischemia reperfusion injury (IRI); liver allograft function/dysfunction; liver transplantation/hepatology; pathology/histopathology; risk assessment/risk stratification; transfusion

Year:  2019        PMID: 31012531     DOI: 10.1111/ajt.15399

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  2 in total

1.  Banff consensus recommendations for steatosis assessment in donor livers.

Authors:  Desley A H Neil; Marta Minervini; Maxwell L Smith; Stefan G Hubscher; Elizabeth M Brunt; A Jake Demetris
Journal:  Hepatology       Date:  2021-12-06       Impact factor: 17.298

2.  Acute Kidney Injury Patterns Following Transplantation of Steatotic Liver Allografts.

Authors:  Caroline Jadlowiec; Maxwell Smith; Matthew Neville; Shennen Mao; Dina Abdelwahab; Kunam Reddy; Adyr Moss; Bashar Aqel; Timucin Taner
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.